Literature DB >> 14578292

Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome.

Anthony J G Hanley1, Lynne E Wagenknecht, Ralph B D'Agostino, Bernard Zinman, Steven M Haffner.   

Abstract

Recently, the metabolic syndrome (MetS) has attracted much attention as a risk cluster for cardiovascular disease. Although it is believed that individuals with the MetS have insulin resistance (IR), there are few data using direct measures of IR such as glucose clamps or frequently sampled intravenous glucose tolerance tests (FSIGTTs). We examined associations of MetS with FSIGTT-derived measures of insulin sensitivity and secretion among nondiabetic subjects in the Insulin Resistance Atherosclerosis Study. Two sets of MetS criteria were evaluated: those from the 1999 World Health Organization (WHO) and the 2001 National Cholesterol Education Program (NCEP). Both WHO and NCEP MetS definitions were significantly associated with risk of being in the lowest quartile of directly measured insulin sensitivity (P < 0.0001 for all subjects as well as within ethnic subgroups). However, the associations with WHO-MetS were stronger for all subjects combined (WHO: odds ratio [OR] = 10.2; 95% CI 7.5-13.9; NCEP: OR = 4.6; 3.4-6.2) and in separate analyses of non-Hispanic whites, blacks, and Hispanics. WHO and NCEP MetS definitions were also significantly associated with risk of being in the lowest quartile of insulin sensitivity-adjusted acute insulin response (AIR) and disposition index (DI; all P < 0.01), although the associations were generally weaker than those for insulin sensitivity and there was no difference between the two definitions in all subjects combined (low AIR, WHO: OR = 1.7, 1.2-2.4; NCEP: OR = 1.7, 1.2-2.5). There were, however, a number of ethnic differences, including a stronger association of NCEP-MetS with low AIR among blacks. WHO-MetS was significantly more sensitive than NCEP-MetS in detecting low insulin sensitivity (65.4 vs. 45.6%, respectively; P < 0.0001), with no significant differences in specificity between the definitions (84.4 vs. 84.6%; P = 0.91), although WHO-MetS had a larger area under the receiver operating characteristic curve (75% vs. 65%; P < 0.0001). In conclusion, although both the WHO and NCEP MetS criteria identify nondiabetic individuals with low insulin sensitivity, the associations were notably stronger using the WHO definition. The definitions are generally less useful for identifying those with low AIR or DI, although NCEP-MetS seems to differentiate black subjects with insulin secretion defects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578292     DOI: 10.2337/diabetes.52.11.2740

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Insulin resistance is not necessarily an essential element of metabolic syndrome.

Authors:  Rudruidee Karnchanasorn; Horng-Yi Ou; Lee-Ming Chuang; Ken C Chiu
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients.

Authors:  Liming Weng; Eoin Quinlivan; Yan Gong; Amber L Beitelshees; Mohamed H Shahin; Stephen T Turner; Arlene B Chapman; John G Gums; Julie A Johnson; Reginald F Frye; Timothy J Garrett; Rhonda M Cooper-DeHoff
Journal:  Metab Syndr Relat Disord       Date:  2015-02-09       Impact factor: 1.894

3.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

4.  Hyperglycemic clamp-derived disposition index is negatively associated with metabolic syndrome severity in obese subjects.

Authors:  Sapna S Shah; Claudia E Ramirez; Alvin C Powers; Chang Yu; Cyndya A Shibao; James M Luther
Journal:  Metabolism       Date:  2016-02-26       Impact factor: 8.694

5.  High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.

Authors:  Cecilia P Chung; Ingrid Avalos; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; C Michael Stein
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

6.  The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based study.

Authors:  Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Walter Chen; Tsai-Chung Li
Journal:  BMC Public Health       Date:  2009-12-23       Impact factor: 3.295

7.  Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).

Authors:  Alireza Esteghamati; Haleh Ashraf; Omid Khalilzadeh; Ali Zandieh; Manouchehr Nakhjavani; Armin Rashidi; Mehrdad Haghazali; Fereshteh Asgari
Journal:  Nutr Metab (Lond)       Date:  2010-04-07       Impact factor: 4.169

Review 8.  The metabolic syndrome: insulin resistance.

Authors:  Nasser Mikhail
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

9.  Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study.

Authors:  Fumiaki Imamura; Kenneth J Mukamal; James B Meigs; José A Luchsinger; Joachim H Ix; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Epidemiol       Date:  2013-05-24       Impact factor: 4.897

Review 10.  Metabolic syndrome and cancer: holistic or reductionist?

Authors:  Katherine Esposito; Annalisa Capuano; Dario Giugliano
Journal:  Endocrine       Date:  2013-09-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.